https://newsroom.davita.com/2025-10-13-davita-inc-schedules-3rd-quarter-2025-investor-conference-call/
DaVita Inc. Schedules 3rd Quarter 2025 Investor Conference Call - Newsroom
Feb 10, 2026 - DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Wednesday, October 29, 2025, at...
davita incconference callschedulesquarterinvestor
https://newsroom.davita.com/press-releases-947/
DaVita Inc. to Present at the 36th Annual J.P. Morgan Healthcare Conference - Newsroom
Dec 21, 2025 - DaVita Inc. (NYSE: DVA), a leading independent medical group and a leading provider of kidney care services in the United States, announced today that it will...
j p morgandavita incat thepresentannual
https://newsroom.davita.com/press-releases-56/
DaVita Inc. Extends Exchange Offer Expiration Date - Newsroom
Dec 21, 2025 - DaVita Inc. announced today that it has extended the expiration date of its offer to exchange its 9 3% Series B Senior Subordinated Notes due 2011, registered...
davita incexchange offerexpiration dateextendsnewsroom
https://investors.davita.com/2025-10-13-davita-inc-schedules-3rd-quarter-2025-investor-conference-call/
DaVita Inc. Schedules 3rd Quarter 2025 Investor Conference Call - Investor
Jan 21, 2026 - DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Wednesday, October 29, 2025, at...
davita incconference callschedulesquarterinvestor
https://quantlogix.ai/stock/DVA
DaVita Inc. (DVA) — Stock Forecast, AI Signal & Analysis | QuantLogix
Buy — QuantLogix 5-factor signal for DaVita Inc. (DVA) as of 2026-10-16 (score 0.44). Live factor breakdown, forecast context, financials, peer comparison, and...
davita incstock forecastsignal analysisdva